filmov
tv
ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM
Показать описание
The benefit of adjuvant chemotherapy for stage II colon cancer is unclear. Measuring circulating tumor DNA after surgery might offer guidance as to whether a patient will benefit. New research findings are summarized in a short video.
0:01:56
ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM
0:03:48
Using ctDNA to Guide Adjuvant Therapy in Stage II Colorectal Cancer
0:02:31
DYNAMIC: ctDNA guiding adjuvant chemotherapy in stage II colon cancer
0:16:41
Can we refine the selection for adjuvant treatment in stage II colon cancer?
0:03:17
Highlights on adjuvant chemotherapy of stage II colon cancer: The DYNAMIC Trial
0:19:53
Stage II Colon Cancer: Can We Refine the Selection for Adjuvant Treatment?
0:04:25
Illumina Oncology | ctDNA-guided treatment in colorectal cancer
0:02:13
Ongoing clinical trials on using ctDNA results to guide GI cancer management
0:01:51
A Positive ctDNA Test after Adjuvant Therapy: 2023 Best of GI
0:15:23
2021 West Oncology | Gastrointestinal Cancers | ctDNA Analysis in Colorectal Cancer
0:12:01
Debate: Is circulating tumor DNA ready to guide adjuvant therapy in colon cancer? - Yes
0:04:31
COBRA: ctDNA to help decide which patients with colon cancer will benefit from adjuvant chemotherapy
0:00:45
The emerging role of ctDNA in cancer diagnostics
0:02:42
What is Circulating Tumor DNA (ctDNA)?
0:23:00
Colon Cancer | 2022 OneOncology Conference
0:15:22
Role of chemotherapy in stage II and stage III colon cancer after surgery - Part 2
0:01:36
Results from KEYNOTE-716: adjuvant therapy with pembrolizumab in high-risk stage II melanoma
1:03:46
Dr Jeanne Tie From Australia discusses her #ctDNA #DYNAMICII clinical trial in #DocTalks
0:06:58
Personalizing ctDNA analysis to predict CRC relapse
0:58:52
ctDNA and MRD | 2023 Best of GI Cancer Conference
0:25:18
Possibilities of ctDNA to guide treatmentin colorectal cancer: precision oncology to come
0:01:08
TOMBOLA: ctDNA-guided adjuvant post-cystectomy immunotherapy in MIBC
0:03:16
The utility of ctDNA in colorectal cancer management
0:00:35
How can ctDNA be used as a biomarker for colon cancer?
Комментарии